Kambiz Yazdi
Stock Analyst at BTIG
(4.24)
# 310
Out of 5,180 analysts
21
Total ratings
57.14%
Success rate
19.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZVRA Zevra Therapeutics | Initiates: Buy | $23 | $9.41 | +144.42% | 1 | Mar 16, 2026 | |
| RAPP Rapport Therapeutics | Maintains: Buy | $47 → $53 | $31.67 | +67.35% | 3 | Mar 11, 2026 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $49 | $40.98 | +19.57% | 3 | Mar 11, 2026 | |
| SION Sionna Therapeutics | Reiterates: Buy | $58 | $41.30 | +40.44% | 4 | Mar 2, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $507 → $843 | $319.28 | +164.03% | 5 | Dec 29, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $16.70 | +37.72% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $24.10 | -21.16% | 2 | Mar 11, 2025 | |
| EYPT EyePoint | Initiates: Buy | $15 | $13.02 | +15.21% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.35 | +271.75% | 1 | Apr 12, 2024 |
Zevra Therapeutics
Mar 16, 2026
Initiates: Buy
Price Target: $23
Current: $9.41
Upside: +144.42%
Rapport Therapeutics
Mar 11, 2026
Maintains: Buy
Price Target: $47 → $53
Current: $31.67
Upside: +67.35%
vTv Therapeutics
Mar 11, 2026
Reiterates: Buy
Price Target: $49
Current: $40.98
Upside: +19.57%
Sionna Therapeutics
Mar 2, 2026
Reiterates: Buy
Price Target: $58
Current: $41.30
Upside: +40.44%
Praxis Precision Medicines
Dec 29, 2025
Maintains: Buy
Price Target: $507 → $843
Current: $319.28
Upside: +164.03%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $16.70
Upside: +37.72%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $24.10
Upside: -21.16%
EyePoint
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $13.02
Upside: +15.21%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.35
Upside: +271.75%